Institut Curie;UNIVERSITE DE MONTPELLIER;CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS
发明人:
申请号：
EP19164367.5
公开号：
EP3536691A1
申请日:
2009.01.12
申请国别(地区):
EP
年份:
2019
代理人:
摘要：
The present invention relates to specific compounds； pharmaceutical composition comprising at least one of said compounds； and the use of at least one of said compounds in preparing a drug to treat, in a subject, a genetic disease resulting from at least one splicing anomaly.
